Kennedy Capital Management, Inc. Collegium Pharmaceutical, Inc Transaction History

Kennedy Capital Management, Inc.

  • $4.27 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$10.7 - $22.24 $258,875 - $538,074
-24,194 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$10.16 - $13.28 $6,908 - $9,030
-680 Reduced 2.73%
24,194 $278,000
Q2 2019

Aug 14, 2019
BUY
$10.62 - $16.59 $264,161 - $412,659
24,874 New
24,874 $327,000

Others Institutions Holding COLL

# of Institutions
256
Shares Held
38.6M
Call Options Held
100K
Put Options Held
21.1K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.04B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Kennedy Capital Management, Inc. Portfolio

Follow Kennedy Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email